Chapter 5: Medical Coding Standardization of Clinical Data

Authors

Synopsis

Author

Mr. Mohammed Shahnawaaz Ahamed,

PharmD Scholar, Department of Pharmacy Practice, Sir C.R.Reddy College of Pharmaceutical Sciences, Eluru, Andhra Pradesh, India

Abstract

Clinical narrative data, captured as free-text descriptions of adverse events and medical histories, presents a fundamental challenge for statistical analysis known as the "Tower of Babel" problem. Without standardization, the thousands of unique ways physicians describe the same medical concept would render global safety aggregation impossible. The solution lies in Medical Coding, the process of mapping verbatim terms to standardized, internationally recognized dictionaries. This discipline relies on two primary pillars: the Medical Dictionary for Regulatory Activities (MedDRA) for coding medical conditions and adverse events, and the World Health Organization Drug Dictionary (WHO-DD) for coding concomitant medications. Mastering MedDRA requires knowing its complex five-level hierarchy and understanding the concept of multiaxiality, where a single disease may link to multiple body systems. Similarly, WHO-DD utilizes the Anatomical Therapeutic Chemical (ATC) classification system to group drugs by their active ingredients and therapeutic indications. The operational reality of coding involves a blend of algorithmic auto-encoding and expert manual review to handle ambiguity, spelling errors, and vague terminology. By applying strict coding guidelines and resolving challenges such as "splitting" versus "lumping" diagnoses, coding professionals ensure that the qualitative language of the patient is converted into the quantitative data required for signal detection and label updates.

Keywords: MedDRA, WHO Drug Dictionary (WHO-DD), Medical Coding, Verbatim Terms, Standardized Dictionaries

VIEW PDF

Published

18 February 2026

How to Cite

Chapter 5: Medical Coding Standardization of Clinical Data. (2026). In Principles and Practice of Pharmacovigilance & Clinical Data Management (pp. 107-133). ThinkPlus Pharma Publications. https://doi.org/10.69613/k0nv6179